1. Steiner T, Salman RA-S, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. International journal of stroke. 2014; 9(7): 840-55. [DOI:10.1111/ijs.12309]

2. Majeed A, Kim Y-K, Roberts RS, Holmström M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010; 41(12): 2860-6. [DOI:10.1161/STROKEAHA.110.593087]

3. Goldstein JN, Fazen LE, Wendell L, Chang Y, Rost NS, Snider R, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocritical care. 2009; 10(1): 28. [DOI:10.1007/s12028-008-9134-3]

4. Gorelick PB, Hier DB, Caplan LR, Langenberg P. Headache in acute cerebrovascular disease. Neurology. 1986; 36(11): 1445. [DOI:10.1212/WNL.36.11.1445]

5. Zissimopoulos A, Vogiatzaki T, Babatsikou F, Velissaratou M, Baloka L, Karathanos E, et al. The role of copeptin in patients with subarachnoid haemorrage. Hellenic journal of nuclear medicine. 2015; 18: 150.

6. Group ISTC. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. The Lancet. 1997; 349(9065): 1569-81. [DOI:10.1016/S0140-6736(97)04011-7]

7. Goba I, Turovska B, Belyakov S, Liepinsh E. Synthesis of Novel Unsymmetrically Substituted 1, 4-Dihydroisonicotinic Acid and its Derivatives. Chemistry of Heterocyclic Compounds. 2013; 49(5): 726-35. [DOI:10.1007/s10593-013-1304-3]

8. McConnell ED, Wei HS, Reitz KM, Kang H, Takano T, Vates GE, et al. Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2016; 36(9): 1537-52. [DOI:10.1177/0271678X15608389]

9. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. Journal of the neurological sciences. 2008; 272(1-2): 83-6. [DOI:10.1016/j.jns.2008.04.032]

10. Lee H-C, Chang K-C, Huang Y-C, Hung J-W, Chiu H-HE, Chen J-J, et al. Readmission, mortality, and first-year medical costs after stroke. Journal of the Chinese Medical Association. 2013; 76(12): 703-14. [DOI:10.1016/j.jcma.2013.08.003]

11. Liang CW, Su K, Liu JJ, Dogan A, Hinson HE. Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage. Journal of neurosurgery. 2015; 123(4): 891-6. [DOI:10.3171/2014.12.JNS141288]

12. Christensen MC, Dawson J, Vincent C. Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity. Adv Ther. 2008; 25(9): 831-41. [DOI:10.1007/s12325-008-0092-0]

13. Caplan LR. Intracerebral haemorrhage. The Lancet. 1992; 339(8794): 656-8. [DOI:10.1016/0140-6736(92)90804-C]

14. An SJ, Kim TJ, Yoon B-W. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. Journal of stroke. 2017; 19(1): 3. [DOI:10.5853/jos.2016.00864]

15. Chen C-C, Lee T-H, Chung C-Y, Chang W-H, Hong J-P, Huang L-T, et al. Symptomatic pulmonary embolism among stroke patients in Taiwan: a retrospective cohort study. Topics in stroke rehabilitation. 2012; 19(5): 361-8. [DOI:10.1310/tsr1905-361]

16. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest. 2001; 119(1): 132S-75S. [DOI:10.1378/chest.119.1_suppl.132S]

17. Weill‐Engerer S, Meaume S, Lahlou A, Piette F, Saint‐Jean O, Sachet A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case‐control multicenter study. Journal of the American Geriatrics Society. 2004; 52(8): 1299-304. [DOI:10.1111/j.1532-5415.2004.52359.x]

18. Graipe A, Binsell‐Gerdin E, Söderström L, Mooe T. Incidence, Time Trends, and Predictors of Intracranial Hemorrhage During Long‐Term Follow‐up After Acute Myocardial Infarction. Journal of the American Heart Association. 2015; 4(12): e002290. [DOI:10.1161/JAHA.115.002290]

19. Berge E, Abdelnoor M, Nakstad P, Sandset P, Group HS. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. The Lancet. 2000; 355(9211): 1205-10. [DOI:10.1016/S0140-6736(00)02085-7]

20. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circulation research. 2016; 118(9): 1340-7. [DOI:10.1161/CIRCRESAHA.115.306841]

21. Khan MT, Ikram A, Saeed O, Afridi T, Sila CA, Smith MS, et al. Deep vein thrombosis in acute stroke-a systemic review of the literature. Cureus. 2017; 9(12). [DOI:10.7759/cureus.1982]

22. Kelly J, Rudd A, Lewis R, Hunt B. Venous thromboembolism after acute stroke. Stroke. 2001; 32(1): 262-7. [DOI:10.1161/01.STR.32.1.262]

23. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. The Lancet Neurology. 2012; 11(1): 101-18. [DOI:10.1016/S1474-4422(11)70264-2]

24. Kamins J, Nguyen P. Neurology Electives Catalog.

25. Arima H, Huang Y, Wang JG, Heeley E, Delcourt C, Parsons M, et al. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke. 2012; 43(8): 2236-8. [DOI:10.1161/STROKEAHA.112.651422]

26. Danese A, Cappellari M, Pancheri E, Mugnai G, Micheletti N, Tomelleri G, et al. The dispersion of myocardial repolarization in ischemic stroke and intracranial hemorrhage. Journal of electrocardiology. 2018; 51(4): 691-5. [DOI:10.1016/j.jelectrocard.2018.05.007]